Literature DB >> 5350403

Cirrhosis following methotrexate administration for psoriasis.

E H Epstein, J D Croft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5350403

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  7 in total

1.  Methotrexate therapy in rheumatoid arthritis. Current status.

Authors:  W S Wilke; A H Mackenzie
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

2.  [Chromosome investigations in lymphocytes and bone marrow from long term methotrexate-treated psoriatics].

Authors:  W Sachsse; R Denk
Journal:  Arch Klin Exp Dermatol       Date:  1970

Review 3.  Hepatotoxicity of methotrexate in rheumatic diseases.

Authors:  S Kevat; M Ahern; P Hall
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

4.  Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis.

Authors:  Lindsey Tilling; Sue Townsend; Joel David
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

5.  Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.

Authors:  M G Dahl; M M Gregory; P J Scheuer
Journal:  Br Med J       Date:  1972-03-11

6.  Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.

Authors:  S B Lanse; G L Arnold; J D Gowans; M M Kaplan
Journal:  Dig Dis Sci       Date:  1985-02       Impact factor: 3.199

7.  Liver damage due to methotrexate in patients with psoriasis.

Authors:  M G Dahl; M M Gregory; P J Scheuer
Journal:  Br Med J       Date:  1971-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.